Metabolic Syndrome Reimbursement Forecast: Outlook Remains Cloudy
Executive Summary
In the near term, the best prospect for establishing a favorable reimbursement climate for metabolic syndrome may be to focus on treating comorbidities
You may also be interested in...
Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA
Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance
Disease Awareness Ads Increase, Along With Firms’ Need For Clarity From FDA
Industry would like greater clarification from FDA on appropriate disease awareness advertising when the agency finalizes its draft guidance
Sanofi-Aventis Acomplia Faces Good Reception From Physicians And Payers
Acomplia'schances of gaining acceptance as treatment for metabolic syndrome are improved by its effects on a range of the disease's comorbidities, according to Decision Resources analyst Donny Wong